Cate Murray 🇨🇦
@catemurray1.bsky.social
(1/7) I'm pleased to welcome four new members to the Stem Cell Network's Board of Directors, John Alho, Wayne Critchley, Susan Marlin, and Liz Williams. Their expertise and experience will undoubtedly enrich our Board's conversations and future direction.
(1/5) SCN is pleased to announce the appointment of four new expert members to its Board of Directors, John Alho, Wayne Critchley, Susan Marlin, and Liz Williams.
Read more. ➡️ stemcellnetwork.ca/stem-cell-ne...
Read more. ➡️ stemcellnetwork.ca/stem-cell-ne...
November 26, 2025 at 1:13 PM
(1/7) I'm pleased to welcome four new members to the Stem Cell Network's Board of Directors, John Alho, Wayne Critchley, Susan Marlin, and Liz Williams. Their expertise and experience will undoubtedly enrich our Board's conversations and future direction.
(1/2) A century after discovering insulin, Canadian innovation is once again poised to change the world — this time through #RegenerativeMedicine and advanced therapeutics.
In an op-ed with Jessica Diniz, President & CEO of @breakthrought1dca.bsky.social,
In an op-ed with Jessica Diniz, President & CEO of @breakthrought1dca.bsky.social,
Curing Type 1 diabetes could be Canada’s legacy
From insulin to regenerative therapy, Canada’s contribution to diabetes research is unmatched. The question is whether we’ll continue to lead or watch others cross the finish line.
www.hilltimes.com
October 30, 2025 at 7:10 PM
(1/2) A century after discovering insulin, Canadian innovation is once again poised to change the world — this time through #RegenerativeMedicine and advanced therapeutics.
In an op-ed with Jessica Diniz, President & CEO of @breakthrought1dca.bsky.social,
In an op-ed with Jessica Diniz, President & CEO of @breakthrought1dca.bsky.social,
(1/2) Canada leads in regenerative medicine research. Now we must lead in delivering regenerative medicine therapies to Canadians. 🇨🇦
Proud to share SCN’s new report outlining how we can prepare Canada’s health system for advanced therapeutics—starting with cell therapies for type 1 diabetes.
Proud to share SCN’s new report outlining how we can prepare Canada’s health system for advanced therapeutics—starting with cell therapies for type 1 diabetes.
(1/3) 📢 SCN is pleased to announce the release of our 'What We Heard' report, Preparing Canada’s Health System for Regenerative Medicines and Advanced Therapeutics: Cell Therapies for Type 1 Diabetes.
🔗 Read the report: stemcellnetwork.ca/wp-content/u...
🔗 Read the report: stemcellnetwork.ca/wp-content/u...
October 27, 2025 at 6:05 PM
(1/2) Canada leads in regenerative medicine research. Now we must lead in delivering regenerative medicine therapies to Canadians. 🇨🇦
Proud to share SCN’s new report outlining how we can prepare Canada’s health system for advanced therapeutics—starting with cell therapies for type 1 diabetes.
Proud to share SCN’s new report outlining how we can prepare Canada’s health system for advanced therapeutics—starting with cell therapies for type 1 diabetes.
Reposted by Cate Murray 🇨🇦
SCN was delighted to sponsor and take part in the Canada Gairdner Awards Gala, celebrating the remarkable achievements of this year’s laureates!
We were also pleased to host three researchers from our community, Tara MacDonald & Stephan Ong Tone.
Congratulations to all the award recipients! 👏
We were also pleased to host three researchers from our community, Tara MacDonald & Stephan Ong Tone.
Congratulations to all the award recipients! 👏
October 24, 2025 at 2:42 PM
SCN was delighted to sponsor and take part in the Canada Gairdner Awards Gala, celebrating the remarkable achievements of this year’s laureates!
We were also pleased to host three researchers from our community, Tara MacDonald & Stephan Ong Tone.
Congratulations to all the award recipients! 👏
We were also pleased to host three researchers from our community, Tara MacDonald & Stephan Ong Tone.
Congratulations to all the award recipients! 👏
Reposted by Cate Murray 🇨🇦
(3/3) It was also great to hear from SCN-funded researcher Timothy Caulfield, who delivered the keynote address. He shared timely insights on the growing threat of misinformation in science and health, and the critical need for evidence-based communication in advancing public trust and policy.
September 23, 2025 at 8:41 PM
(3/3) It was also great to hear from SCN-funded researcher Timothy Caulfield, who delivered the keynote address. He shared timely insights on the growing threat of misinformation in science and health, and the critical need for evidence-based communication in advancing public trust and policy.
Reposted by Cate Murray 🇨🇦
(2/3) the challenges holding us back, and a bold call for a coordinated national strategy to accelerate innovation, commercialization, and patient access.
Canada must lead from discovery through to delivering therapies that benefit Canadians, making sure our science and talent remain here at home.
Canada must lead from discovery through to delivering therapies that benefit Canadians, making sure our science and talent remain here at home.
September 23, 2025 at 8:41 PM
(2/3) the challenges holding us back, and a bold call for a coordinated national strategy to accelerate innovation, commercialization, and patient access.
Canada must lead from discovery through to delivering therapies that benefit Canadians, making sure our science and talent remain here at home.
Canada must lead from discovery through to delivering therapies that benefit Canadians, making sure our science and talent remain here at home.
Reposted by Cate Murray 🇨🇦
(1/3) We were pleased to have SCN President and CEO @catemurray1.bsky.social deliver a speech at Life Sciences Ontario’s 16th Annual Ideas to Action Forum. ✨
Cate presented a vision for putting Canada first in #RegenMed, highlighting the incredible Canadian breakthroughs happening right now,
Cate presented a vision for putting Canada first in #RegenMed, highlighting the incredible Canadian breakthroughs happening right now,
September 23, 2025 at 8:41 PM
(1/3) We were pleased to have SCN President and CEO @catemurray1.bsky.social deliver a speech at Life Sciences Ontario’s 16th Annual Ideas to Action Forum. ✨
Cate presented a vision for putting Canada first in #RegenMed, highlighting the incredible Canadian breakthroughs happening right now,
Cate presented a vision for putting Canada first in #RegenMed, highlighting the incredible Canadian breakthroughs happening right now,
(1/3) Grande nouvelle pour les entreprises biotechnologiques canadiennes spécialisées dans la médecine régénératrice! 🔬
Le programme de Subventions d’incubation du RCS est désormais ouvert et nous acceptons actuellement les demandes pour la première étape du processus de demande.
Le programme de Subventions d’incubation du RCS est désormais ouvert et nous acceptons actuellement les demandes pour la première étape du processus de demande.
(1/2) 📢 L’étape 1 du processus de candidature A DÉMARRÉ!
Le nouveau Programme de subventions d’incubation du RCS soutient les entreprises biotechnologiques canadiennes en prédémarrage et en démarrage #MédRégén.🇨🇦
🔗 stemcellnetwork.ca/fr/recherche...
Le nouveau Programme de subventions d’incubation du RCS soutient les entreprises biotechnologiques canadiennes en prédémarrage et en démarrage #MédRégén.🇨🇦
🔗 stemcellnetwork.ca/fr/recherche...
September 8, 2025 at 1:18 PM
(1/3) Grande nouvelle pour les entreprises biotechnologiques canadiennes spécialisées dans la médecine régénératrice! 🔬
Le programme de Subventions d’incubation du RCS est désormais ouvert et nous acceptons actuellement les demandes pour la première étape du processus de demande.
Le programme de Subventions d’incubation du RCS est désormais ouvert et nous acceptons actuellement les demandes pour la première étape du processus de demande.
(1/3) Exciting news for Canadian #RegenerativeMedicine biotechs! 🔬
SCN's Incubation Investment Award Program is now open and accepting Stage 1 applications.
SCN's Incubation Investment Award Program is now open and accepting Stage 1 applications.
📢 Stage 1 applications are OPEN!
SCN’s new Incubation Investment Award Program supports Canadian pre-seed & seed-staged #RegenMed biotech. 🇨🇦
💰 $250K–$1M per company, milestone-based over 2–3 years
🗓️ Sept 26, 11:59 pm PT
🔗 https://stemcellnetwork.ca/research/incubation-investment-award-program/
SCN’s new Incubation Investment Award Program supports Canadian pre-seed & seed-staged #RegenMed biotech. 🇨🇦
💰 $250K–$1M per company, milestone-based over 2–3 years
🗓️ Sept 26, 11:59 pm PT
🔗 https://stemcellnetwork.ca/research/incubation-investment-award-program/
September 8, 2025 at 1:17 PM
(1/3) Exciting news for Canadian #RegenerativeMedicine biotechs! 🔬
SCN's Incubation Investment Award Program is now open and accepting Stage 1 applications.
SCN's Incubation Investment Award Program is now open and accepting Stage 1 applications.
(1/2) Nous sommes fiers de présenter le Rapport annuel 2024/2025 du RCS, qui met en vitrine les formidables progrès de la recherche canadienne 🇨🇦 sur les cellules souches et la médecine régénératrice.
🔗 stemcellnetwork.ca/wp-content/u...
🔗 stemcellnetwork.ca/wp-content/u...
August 18, 2025 at 1:18 PM
(1/2) Nous sommes fiers de présenter le Rapport annuel 2024/2025 du RCS, qui met en vitrine les formidables progrès de la recherche canadienne 🇨🇦 sur les cellules souches et la médecine régénératrice.
🔗 stemcellnetwork.ca/wp-content/u...
🔗 stemcellnetwork.ca/wp-content/u...
In Case You Missed it! Proud to share SCN’s 2024/2025 Annual Report — highlighting the amazing progress in stem cell & regenerative medicine research across Canada. 🇨🇦
Thanks to our researchers, partners & community — you’re shaping a healthier future. ✨
🔗 stemcellnetwork.ca/wp-content/u...
Thanks to our researchers, partners & community — you’re shaping a healthier future. ✨
🔗 stemcellnetwork.ca/wp-content/u...
August 18, 2025 at 1:15 PM
In Case You Missed it! Proud to share SCN’s 2024/2025 Annual Report — highlighting the amazing progress in stem cell & regenerative medicine research across Canada. 🇨🇦
Thanks to our researchers, partners & community — you’re shaping a healthier future. ✨
🔗 stemcellnetwork.ca/wp-content/u...
Thanks to our researchers, partners & community — you’re shaping a healthier future. ✨
🔗 stemcellnetwork.ca/wp-content/u...
Reposted by Cate Murray 🇨🇦
(1/2) 📢 NOTEZ LA DATE À VOTRE AGENDA! Un nouveau programme destiné aux #biotechs canadiennes de #MédecineRégénératrice va être lancé 🇨🇦
🔗 stemcellnetwork.ca/fr/recherche...
🔗 stemcellnetwork.ca/fr/recherche...
August 6, 2025 at 1:27 PM
(1/2) 📢 NOTEZ LA DATE À VOTRE AGENDA! Un nouveau programme destiné aux #biotechs canadiennes de #MédecineRégénératrice va être lancé 🇨🇦
🔗 stemcellnetwork.ca/fr/recherche...
🔗 stemcellnetwork.ca/fr/recherche...
Reposted by Cate Murray 🇨🇦
📢 SAVE THE DATE! A new program is coming, specific for Canadian #biotechs in #RegenerativeMedicine 🇨🇦
SCN’s Incubation Investment Award Program will support pre-seed & seed-staged RM companies with:
💰 $250K–$1M per company
⏳ 2–3 yrs, milestone-based tranches
🔗 stemcellnetwork.ca/research/inc...
SCN’s Incubation Investment Award Program will support pre-seed & seed-staged RM companies with:
💰 $250K–$1M per company
⏳ 2–3 yrs, milestone-based tranches
🔗 stemcellnetwork.ca/research/inc...
August 6, 2025 at 1:27 PM
📢 SAVE THE DATE! A new program is coming, specific for Canadian #biotechs in #RegenerativeMedicine 🇨🇦
SCN’s Incubation Investment Award Program will support pre-seed & seed-staged RM companies with:
💰 $250K–$1M per company
⏳ 2–3 yrs, milestone-based tranches
🔗 stemcellnetwork.ca/research/inc...
SCN’s Incubation Investment Award Program will support pre-seed & seed-staged RM companies with:
💰 $250K–$1M per company
⏳ 2–3 yrs, milestone-based tranches
🔗 stemcellnetwork.ca/research/inc...
Je suis ravie d'annoncer que le RCS a investi 13,5 millions de dollars dans 36 nouveaux projets de recherche et #EssaisCliniques au Canada — afin de faire progresser l'innovation dans le domaine des cellules souches et de la #MédecineRégénératrice!
👉 stemcellnetwork.ca/research/res...
👉 stemcellnetwork.ca/research/res...
🚨 NOUVELLE IMPORTANTE! Le RCS annonce un investissement de 33 M$ pour soutenir 36 projets de recherche et #EssaisCliniques en #MédecineRégénératrice!
En savoir plus. ➡️ stemcellnetwork.ca/fr/recherche...
En savoir plus. ➡️ stemcellnetwork.ca/fr/recherche...
Le Réseau de cellules souches canadien annonce un investissement de 33 M$
YouTube video by Stem Cell Network - Réseau de cellules souches
youtu.be
June 16, 2025 at 1:11 PM
Je suis ravie d'annoncer que le RCS a investi 13,5 millions de dollars dans 36 nouveaux projets de recherche et #EssaisCliniques au Canada — afin de faire progresser l'innovation dans le domaine des cellules souches et de la #MédecineRégénératrice!
👉 stemcellnetwork.ca/research/res...
👉 stemcellnetwork.ca/research/res...
I’m excited to share that SCN is investing $13.5 million in 36 new research projects and #ClinicalTrials across the country — driving forward innovation in #StemCells and #RegenMed! 🇨🇦
👉 Learn more about the announcement and explore the projects we're funding: stemcellnetwork.ca/research/res...
👉 Learn more about the announcement and explore the projects we're funding: stemcellnetwork.ca/research/res...
🚨 BIG NEWS! SCN announces $33M to advance 36 #RegenerativeMedicine research projects and #ClinicalTrials!
Learn more. ➡️ stemcellnetwork.ca/research/res...
Learn more. ➡️ stemcellnetwork.ca/research/res...
The Stem Cell Network Announces $33M to Advance Regenerative Medicine Research and Clinical Trials
YouTube video by Stem Cell Network - Réseau de cellules souches
youtu.be
June 16, 2025 at 1:10 PM
I’m excited to share that SCN is investing $13.5 million in 36 new research projects and #ClinicalTrials across the country — driving forward innovation in #StemCells and #RegenMed! 🇨🇦
👉 Learn more about the announcement and explore the projects we're funding: stemcellnetwork.ca/research/res...
👉 Learn more about the announcement and explore the projects we're funding: stemcellnetwork.ca/research/res...
Reposted by Cate Murray 🇨🇦
✨ SCN President & CEO @catemurray1.bsky.social was featured in a Purpose-Led CEO Interview Series spotlighting leaders driving meaningful change.
Read more about what inspires her, how she leads with purpose, and why the future of #RegenMed starts in Canada. 🇨🇦
🔗 www.watsoninc.ca/purpose-led-...
Read more about what inspires her, how she leads with purpose, and why the future of #RegenMed starts in Canada. 🇨🇦
🔗 www.watsoninc.ca/purpose-led-...
Purpose-Led CEO Interview Series: Cate Murray, President & CEO, Stem Cell Network | Watson Advisors Inc.
Purpose-led CEO Cate Murray shares her path, what drives her, and how she’s advancing health equity and regenerative medicine in Canada.
www.watsoninc.ca
May 16, 2025 at 7:37 PM
✨ SCN President & CEO @catemurray1.bsky.social was featured in a Purpose-Led CEO Interview Series spotlighting leaders driving meaningful change.
Read more about what inspires her, how she leads with purpose, and why the future of #RegenMed starts in Canada. 🇨🇦
🔗 www.watsoninc.ca/purpose-led-...
Read more about what inspires her, how she leads with purpose, and why the future of #RegenMed starts in Canada. 🇨🇦
🔗 www.watsoninc.ca/purpose-led-...
Had a fantastic time at the 2025 LSO Awards, celebrating the incredible talent across Canada’s #LifeSciences sector.
Huge congrats to Dr. Janet Rossant on her Lifetime Achievement Award—so well deserved! 👏
Grateful to share the evening with amazing colleagues and friends.
Huge congrats to Dr. Janet Rossant on her Lifetime Achievement Award—so well deserved! 👏
Grateful to share the evening with amazing colleagues and friends.
May 15, 2025 at 2:59 PM
Had a fantastic time at the 2025 LSO Awards, celebrating the incredible talent across Canada’s #LifeSciences sector.
Huge congrats to Dr. Janet Rossant on her Lifetime Achievement Award—so well deserved! 👏
Grateful to share the evening with amazing colleagues and friends.
Huge congrats to Dr. Janet Rossant on her Lifetime Achievement Award—so well deserved! 👏
Grateful to share the evening with amazing colleagues and friends.
(1/2) We've been spending some time connecting with Canada's #RegenerativeMedicine research community to understand how US policy and funding cuts are impacting them.
About half of the respondents told us they've been impacted, with 90% noting rising costs due to tariffs.
About half of the respondents told us they've been impacted, with 90% noting rising costs due to tariffs.
stemcellnetwork.ca
May 9, 2025 at 4:52 PM
(1/2) We've been spending some time connecting with Canada's #RegenerativeMedicine research community to understand how US policy and funding cuts are impacting them.
About half of the respondents told us they've been impacted, with 90% noting rising costs due to tariffs.
About half of the respondents told us they've been impacted, with 90% noting rising costs due to tariffs.
(1/2) An incredible few days at the Bloom Burton & Co. Healthcare Investor Conference & MaRs Impact Health. I was impressed with the commitment, resilience and energy of Canada’s biotech and research community. 🔬
May 7, 2025 at 6:58 PM
(1/2) An incredible few days at the Bloom Burton & Co. Healthcare Investor Conference & MaRs Impact Health. I was impressed with the commitment, resilience and energy of Canada’s biotech and research community. 🔬
Reposted by Cate Murray 🇨🇦
(2/2) ... had great conversations about where the field is headed and how we can continue to drive Canadian innovation forward. 🇨🇦
SCN and Capital BioVentures were also proud to support CEREBRO Therapeutics and CEO Martin Levesque, helping them showcase their work to the community.
SCN and Capital BioVentures were also proud to support CEREBRO Therapeutics and CEO Martin Levesque, helping them showcase their work to the community.
May 7, 2025 at 5:13 PM
(2/2) ... had great conversations about where the field is headed and how we can continue to drive Canadian innovation forward. 🇨🇦
SCN and Capital BioVentures were also proud to support CEREBRO Therapeutics and CEO Martin Levesque, helping them showcase their work to the community.
SCN and Capital BioVentures were also proud to support CEREBRO Therapeutics and CEO Martin Levesque, helping them showcase their work to the community.
Reposted by Cate Murray 🇨🇦
(1/2) It was an exciting few days at the Bloom Burton & Co. Healthcare Investor Conference in Toronto, connecting with leaders, investors, and innovators across the health and biotech space. 🤝
SCN’s President & CEO, @catemurray1.bsky.social...
SCN’s President & CEO, @catemurray1.bsky.social...
May 7, 2025 at 5:13 PM
(1/2) It was an exciting few days at the Bloom Burton & Co. Healthcare Investor Conference in Toronto, connecting with leaders, investors, and innovators across the health and biotech space. 🤝
SCN’s President & CEO, @catemurray1.bsky.social...
SCN’s President & CEO, @catemurray1.bsky.social...
(1/2) On behalf of SCN, we extend our deepest sympathies to the victims, their families, and Vancouver’s Filipino community following the tragic events at the Lapu Lapu Festival.
April 28, 2025 at 4:54 PM
(1/2) On behalf of SCN, we extend our deepest sympathies to the victims, their families, and Vancouver’s Filipino community following the tragic events at the Lapu Lapu Festival.
(1/2) Canada’s #ClinicalTrials ecosystem is strong — but global competition is fierce, and the moment to act is now.
I’m looking forward to joining a dynamic panel on April 25 to discuss how we can take Canada’s clinical trial leadership to the next level.
🔗 us06web.zoom.us/webinar/regi...
I’m looking forward to joining a dynamic panel on April 25 to discuss how we can take Canada’s clinical trial leadership to the next level.
🔗 us06web.zoom.us/webinar/regi...
April 24, 2025 at 2:50 PM
(1/2) Canada’s #ClinicalTrials ecosystem is strong — but global competition is fierce, and the moment to act is now.
I’m looking forward to joining a dynamic panel on April 25 to discuss how we can take Canada’s clinical trial leadership to the next level.
🔗 us06web.zoom.us/webinar/regi...
I’m looking forward to joining a dynamic panel on April 25 to discuss how we can take Canada’s clinical trial leadership to the next level.
🔗 us06web.zoom.us/webinar/regi...
Reposted by Cate Murray 🇨🇦
Health misinformation: How to identify reliable sources online iuhealth.org/thrive/healt...
- Be skeptical of sensational quick-fixes or $ asks
- Medical information affects everyone
- Health misinformation is dangerous
- Fact-check suspicious health claims
- Help fight bunk!
- Be skeptical of sensational quick-fixes or $ asks
- Medical information affects everyone
- Health misinformation is dangerous
- Fact-check suspicious health claims
- Help fight bunk!
iuhealth.org
April 11, 2025 at 3:20 PM
Health misinformation: How to identify reliable sources online iuhealth.org/thrive/healt...
- Be skeptical of sensational quick-fixes or $ asks
- Medical information affects everyone
- Health misinformation is dangerous
- Fact-check suspicious health claims
- Help fight bunk!
- Be skeptical of sensational quick-fixes or $ asks
- Medical information affects everyone
- Health misinformation is dangerous
- Fact-check suspicious health claims
- Help fight bunk!
Reposted by Cate Murray 🇨🇦
RFK Jr’s proposal to remove public commentary from US health policy is a threat to science & public health www.bmj.com/content/389/...
"The ability to participate in regulatory decision making is not a privilege: it’s a legal requirement and a fundamental right in a democratic society."
"The ability to participate in regulatory decision making is not a privilege: it’s a legal requirement and a fundamental right in a democratic society."
Robert F Kennedy Jr’s proposal to remove public commentary from US health policy is a threat to science and public health
With confidence and trust in science and public health already under pressure, we must double down on transparency and public participation in policy decisions, write Liz Salmi and colleagues
Since ...
www.bmj.com
April 5, 2025 at 4:33 PM
RFK Jr’s proposal to remove public commentary from US health policy is a threat to science & public health www.bmj.com/content/389/...
"The ability to participate in regulatory decision making is not a privilege: it’s a legal requirement and a fundamental right in a democratic society."
"The ability to participate in regulatory decision making is not a privilege: it’s a legal requirement and a fundamental right in a democratic society."